HIF2α cooperates with RAS to promote lung tumorigenesis in mice

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Targeting HIF-1 for cancer therapy

Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761 · see citing works

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works

Tumorigenesis and the angiogenic switch

Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559 · see citing works

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · see citing works

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Yang, J., & Weinberg, R. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,135 · see citing works

An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523 · see citing works

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · see citing works

Cellular and developmental control of O ₂ homeostasis by hypoxia-inducible factor 1α

Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · see citing works

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Bild, A., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D. A. D., Joshi, M.-B., Harpole, D. H., Lancaster, J. M., Berchuck, A., et al. (2005) · Nature · doi:10.1038/nature04296 · Cited by 2,032 · see citing works

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966 · see citing works

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works

VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells

Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856 · see citing works

Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma

Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,776 · see citing works

HIF‐1α is required for solid tumor formation and embryonic vascularization

Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579 · see citing works

Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways

Önder, T. T., Gupta, P. B., Mani, S. A., Yang, J., Lander, E. S., & Weinberg, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2938 · Cited by 1,527 · see citing works

Untitled work

(2000) · PubMed · Cited by 1,445 · see citing works

Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386 · see citing works

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · see citing works

The impact of O2 availability on human cancer

Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365 · see citing works

Direct regulation of TWIST by HIF-1α promotes metastasis

Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345 · see citing works

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

Shedden, K., Taylor, J. M. G., Misek, D. E., Chang, A. C., Hanash, S., Kuick, R. D., Beer, D. G., Enkemann, S. A., Yeatman, T. J., Eschrich, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1790 · Cited by 1,194 · see citing works

Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin

Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186 · see citing works

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · see citing works

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · see citing works

LKB1 modulates lung cancer differentiation and metastasis

Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature · doi:10.1038/nature06030 · Cited by 1,064 · see citing works

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma

Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works

Role of VHL Gene Mutation in Human Cancer

Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 940 · see citing works

Loss of <i>PTEN</i> facilitates HIF-1-mediated gene expression

Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes &amp; Development · doi:10.1101/gad.14.4.391 · Cited by 840 · see citing works

Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells

Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 815 · see citing works

Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 786 · see citing works

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · see citing works

Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F., et al. (2002) · Nature Medicine · doi:10.1038/nm721 · Cited by 733 · see citing works

The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer

Kaelin, W. G. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2502 · Cited by 729 · see citing works

Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach

Verrecchia, F., Chu, M., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664 · see citing works

The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development

Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes &amp; Development · doi:10.1101/gad.12.21.3320 · Cited by 647 · see citing works

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611 · see citing works

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604 · see citing works

Dissecting tumour pathophysiology using intravital microscopy

Jain, R. K., Munn, L. L., & Fukumura, D. (2002) · Nature reviews. Cancer · doi:10.1038/nrc778 · Cited by 595 · see citing works

Induction and apoptotic regression of lung adenocarcinomas by regulation of a <i>K-Ras</i> transgene in the presence and absence of tumor suppressor genes

Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., & Varmus, H. E. (2001) · Genes &amp; Development · doi:10.1101/gad.947701 · Cited by 582 · see citing works

The Differential Effects of Mutant <i>p53</i> Alleles on Advanced Murine Lung Cancer

Jackson, E. L., Olive, K. P., Tuveson, D. A., Bronson, R., Crowley, D., Brown, M., & Jacks, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2193 · Cited by 553 · see citing works

TSC2 regulates VEGF through mTOR-dependent and -independent pathways

Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528 · see citing works

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells

FALCO, E. D., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4423 · Cited by 519 · see citing works

Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cellsPreprint

Cole, M. F., Johnstone, S. E., Newman, J. J., Kagey, M. H., & Young, R. A. (2008) · Genes & Development · doi:10.1101/gad.1642408 · Cited by 514 · see citing works

HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma

Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493 · see citing works

HIF activation identifies early lesions in VHL kidneys

Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483 · see citing works

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Turley, H., Talks, K., Pezzella, F., Gatter, K. C., & Harris, A. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2018 · Cited by 478 · see citing works

Acute postnatal ablation of <i>Hif-2</i> α results in anemia

Gruber, M., Hu, C.-J., Johnson, R. S., Brown, E. J., Keith, B., & Simon, M. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608382104 · Cited by 457 · see citing works

The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma

Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 433 · see citing works

Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor

Haase, V. H., Glickman, J. N., Socolovsky, M., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1583 · Cited by 421 · see citing works

Hypoxia-Inducible Factor-1-Dependent Repression of <i>E-cadherin</i> in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B

Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., & Semenza, G. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3719 · Cited by 415 · see citing works

The hypoxic response of tumors is dependent on their microenvironment

Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.-P., Johnson, R. S., & Bergers, G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00194-6 · Cited by 408 · see citing works

From signatures to models: understanding cancer using microarrays

Segal, E., Friedman, N., Kaminski, N., Regev, A., & Koller, D. (2005) · Nature Genetics · doi:10.1038/ng1561 · Cited by 380 · see citing works

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Zhou, B.-B., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y. Y. C., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 370 · see citing works

Renal Cyst Development in Mice with Conditional Inactivation of the von Hippel-Lindau Tumor Suppressor

Rankin, E. B., Tomaszewski, J. E., & Haase, V. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3241 · Cited by 356 · see citing works

The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1α and HIF-2α

Hu, C.-J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0419 · Cited by 355 · see citing works

Hypoxia-Inducible Factor-1-Dependent Repression of E-cadherin in von Hippel-Lindau Tumor Suppressor—Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B

Gordon, M. S. (2007) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70352-x · Cited by 346 · see citing works

Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression

Liao, D., Corle, C., Seagroves, T. N., & Johnson, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2701 · Cited by 339 · see citing works

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer

Socinski, M. A., Novello, S., Brahmer, J. R., Rosell, R., Sánchez, J. M., Belani, C. P., Govindan, R., Atkins, J. N., Gillenwater, H. H., Pallarés, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9303 · Cited by 324 · see citing works

Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α in HEK293T Cells

Wang, V., Davis, D. A., Haque, M., Huang, E. L., & Yarchoan, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4130 · Cited by 309 · see citing works

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1αPreprint

Elson, D. A., Thurston, G., Huang, E. L., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 297 · see citing works

Expression profiling of epithelial plasticity in tumor progression

Jechlinger, M., Grünert, S., Tamir, I. H., Janda, E., Lüdemann, S. K., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 295 · see citing works

Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.

Fukuda, R., Kelly, B., & Semenza, G. L. (2003) · PubMed · Cited by 293 · see citing works

An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers

Le, Q., Chen, E. Y., Salim, A., Cao, H., Kong, C. S., Whyte, R. I., Donington, J. S., Cannon, W., Wakelee, H. A., Tibshirani, R. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2049 · Cited by 293 · see citing works

Rapid and efficient homing of human CD34+CD38−/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice

Kollet, Ó., Spiegel, A., Peled, A., Petit, I., Byk, T., Hershkoviz, R., Guetta, E., Barkai, G., Nagler, A., & Lapidot, T. (2001) · Blood · doi:10.1182/blood.v97.10.3283 · Cited by 290 · see citing works

Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer

Swinson, D., Jones, J. L., Richardson, D. L., Wykoff, C. C., Turley, H., Pastorek, J., Taub, N. A., Harris, A. L., & O'Byrne, K. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.132 · Cited by 288 · see citing works

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 263 · see citing works

Regulation of E-cadherin Expression by <i>VHL</i> and Hypoxia-Inducible Factor

Esteban, M. A., Tran, M. G. B., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., Raval, R., O'Brien, T. S., & Maxwell, P. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2670 · Cited by 262 · see citing works

Three-gene prognostic classifier for early-stage non small-cell lung cancer

Lau, S. K., Boutros, P. C., Pintilie, M., Blackhall, F. H., Zhu, C.-Q., Strumpf, D., Johnston, M. R., Darling, G., Keshavjee, S., Waddell, T. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0352 · Cited by 255 · see citing works

VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail

Evans, A. J., Russell, R. C., Roche, O., Burry, T. N., Fish, J. E., Chow, V. W. K., Kim, W. Y., Saravanan, A., Maynard, M. A., Gervais, M. L., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00892-06 · Cited by 248 · see citing works

Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors

Zimmer, M., Doucette, D., Siddiqui, N., & Iliopoulos, O. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.89.2.2 · Cited by 244 · see citing works

Erratum: Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F., et al. (2002) · Nature Medicine · doi:10.1038/nm1102-1329b · Cited by 237 · see citing works

Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo

Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235 · see citing works

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

Fürstenberger, G., von Moos, R., Lucas, R., Thurlimann, B. J. K., Senn, H.-J., Hamacher, J., & Boneberg, E.-M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602952 · Cited by 205 · see citing works

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

Meuwissen, R. L. J., Linn, S. C., van der Valk, M., Mooi, W. J., & Berns, A. J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204837 · Cited by 200 · see citing works

Genetic evidence for a tumor suppressor role of HIF-2α

Acker, T., Díez‐Juan, A., Aragonés, J., Tjwa, M., Brusselmans, K., Moons, L., Fukumura, D., Moreno-Murciano, P., Herbert, J., Burger, A. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.003 · Cited by 184 · see citing works

Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non-small Cell Lung Cancer

Dome, B., Timar, J., Dobos, J., Meszaros, L., Raso, E., Paku, S., Kenessey, I., Ostoros, G., Magyar, M., Ladanyi, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4654 · Cited by 184 · see citing works

Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer

Kim, S. J., Rabbani, Z. N., Dewhirst, M. W., Vujašković, Ž., Vollmer, R. T., Schreiber, E.-G., Oosterwijk, E., & Kelley, M. J. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.036 · Cited by 166 · see citing works

Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth

Mack, F. A., Rathmell, W. K., Arsham, A. M., Gnarra, J., Keith, B., & Simon, M. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00240-4 · Cited by 160 · see citing works

HIF-1α regulates epithelial inflammation by cell autonomous NFκB activation and paracrine stromal remodeling

Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., & Arbeit, J. M. (2008) · Blood · doi:10.1182/blood-2007-10-115758 · Cited by 151 · see citing works

The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α

Gort, E. H., van Haaften, G. W., Verlaan-Klink, I., Groot, A. J., Plasterk, R. H. A., Shvarts, A., Suijkerbuijk, K. P. M., van Laar, T., van der Wall, E., Raman, V., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210795 · Cited by 133 · see citing works

Significance of circulating endothelial progenitor cells in hepatocellular carcinoma†

Ho, J. W., Pang, R. W. C., Lau, C. P.-Y., Sun, C. K.-W., Yu, W. C., Fan, S. T., & Poon, R. T. P. (2006) · Hepatology · doi:10.1002/hep.21353 · Cited by 133 · see citing works

Pten Inactivation Accelerates Oncogenic K-ras –Initiated Tumorigenesis in a Mouse Model of Lung Cancer

Iwanaga, K., Yang, Y., Raso, M. G., Ma, L., Hanna, A. E., Thilaganathan, N., Moghaddam, S. J., Evans, C. M., Li, H., Cai, W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3117 · Cited by 116 · see citing works

Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.

Ma, W., Tessarollo, L., Hong, S., Baba, M., Southon, E. A., Back, T. C., Spence, S. E., Lobe, C. G., Sharma, N. D., Maher, G., et al. (2003) · PubMed · Cited by 112 · see citing works

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene

Wykoff, C. C., Sotiriou, C. P., Cockman, M. E., Ratcliffe, P. J., Maxwell, P. H., Liu, E., & Harris, A. L. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601657 · Cited by 99 · see citing works

Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells

Kenny, P. A., Enver, T., & Ashworth, A. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-3 · Cited by 61 · see citing works

Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas

Zheng, P., Hop, W. C. J., Luider, T. M., Smitt, P. A. E. S., & Kros, J. M. (2007) · Annals of Neurology · doi:10.1002/ana.21151 · Cited by 56 · see citing works

Hypoxia-Inducible Factor-1 Facilitates Cervical Cancer Progression in Human Papillomavirus Type 16 Transgenic Mice

Lu, Z. H., Wright, J. D., Belt, B. A., Cardiff, R. D., & Arbeit, J. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061138 · Cited by 37 · see citing works

Circulating Endothelial Progenitor Cells

Bertolini, F., Mancuso, P., & Kerbel, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmc052670 · Cited by 18 · see citing works

Hypoxia-inducible factors and the response to hypoxic stress

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · see citing works

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · see citing works

Hypoxic control of metastasis

Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works

Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis

Henderson, W. R., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y.-T., Zhou, B., Borok, Z., Knight, D. A., & Kahn, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001520107 · Cited by 464 · see citing works

Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis

Chapman, H. A. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142225 · Cited by 409 · see citing works

The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion

Koh, M. Y., Lemos, R., Liu, X., & Powis, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4142 · Cited by 350 · see citing works

Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond

Tam, S. Y., Wu, V., & Law, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 304 · see citing works

Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC

Joseph, J. P., Harishankar, M. K., Pillai, A. A., & Devi, A. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.004 · Cited by 281 · see citing works

HIF and the Lung: Role of Hypoxia-inducible Factors in Pulmonary Development and Disease

Shimoda, L. A., & Semenza, G. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1393pp · Cited by 272 · see citing works

Molecular Biology of Lung Cancer: Clinical Implications

Larsen, J. E., & Minna, J. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.003 · Cited by 247 · see citing works

Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors

Carretero, J., Shimamura, T., Rikova, K., Jackson, A. L., Wilkerson, M. D., Borgman, C. L., Buttarazzi, M., Sanofsky, B. A., McNamara, K. L., Brandstetter, K. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.026 · Cited by 243 · see citing works

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype

Piao, Y., Liang, J., Holmes, L., Zurita, A. J., Henry, V., Heymach, J. V., & de Groot, J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos158 · Cited by 227 · see citing works

Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer

Faget, J., Groeneveld, S., Boivin, G., Sankar, M., Zangger, N., Garcia, M., Guex, N., Zlobec, I., Steiner, L., Piersigilli, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.052 · Cited by 219 · see citing works

Molecular biology of lung cancer: Clinical implications

Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 210 · see citing works

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

Han, X., Li, F., Fang, Z., Gao, Y., Li, F., Fang, R., Yao, S., Sun, Y., Li, L., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms4261 · Cited by 193 · see citing works

Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape

Chouaı̈b, S., Messai, Y., Couvé, S., Escudier, B. J., Hasmim, M., & Noman, M. Z. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00021 · Cited by 180 · see citing works

RAS-mediated oncogenic signaling pathways in human malignancies

Khan, A. Q., Kuttikrishnan, S., Siveen, K. S., Prabhu, K. S., Shanmugakonar, M., Al‐Naemi, H. A., Haris, M., Dermime, S., & Shahab Uddin, M. S. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.03.001 · Cited by 179 · see citing works

The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness

Bao, B., Azmi, A. S., Ali, S. S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180 · see citing works

Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities

Beckers, C., Pruschy, M. N., & Vetrugno, I. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.006 · Cited by 182 · see citing works

Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms

Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164 · see citing works

Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment

García, C. J. G., Huang, Y., Fuentes, N. R., Turner, M. C., Monberg, M. E., Lin, D., Nguyen, N. D., Fujimoto, T. N., Zhao, J., Lee, J. J., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.024 · Cited by 159 · see citing works

Molecular definition of a metastatic lung cancer state reveals a targetable CD109–Janus kinase–Stat axis

Chuang, C.-H., Greenside, P., Rogers, Z. N., Brady Jennifer, J., Yang, D., Ma, R. K., Caswell, D. R., Chiou, S., Winters, A. F., Grüner, B. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4285 · Cited by 151 · see citing works

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Shi, R., Liao, C., & Zhang, Q. H. (2021) · Cells · doi:10.3390/cells10030678 · Cited by 148 · see citing works

HIF1α and HIF2α independently activate SRC to promote melanoma metastases

Hanna, S. C., Krishnan, B., Bailey, S. T., Moschos, S. J., Kuan, P.-F., Shimamura, T., Osborne, L. D., Siegel, M. B., Duncan, L. M., O’Brien, E. T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66715 · Cited by 147 · see citing works

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

Huang, Y., Lin, D., & Taniguchi, C. M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9178-y · Cited by 144 · see citing works

HIF-2α deletion promotes Kras-driven lung tumor development

Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130 · see citing works

Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3

Masszi, A., Speight, P., Charbonney, E., Lodyga, M., Nakano, H., Szászi, K., & Kapùs, A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200906155 · Cited by 130 · see citing works

Chemotherapy and signaling

Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., & Astsaturov, I. A. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.9.13738 · Cited by 118 · see citing works

A SUMOylation-Dependent Pathway Regulates SIRT1 Transcription and Lung Cancer Metastasis

Sun, L., Li, H., Chen, J., Dehennaut, V., Zhao, Y., Yang, Y., Iwasaki, Y., Kahn‐Perlès, B., Leprince, D., Chen, Q., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt118 · Cited by 111 · see citing works

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

Boominathan, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9257-9 · Cited by 110 · see citing works

The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis

Myszczyszyn, A., Czarnecka, A. M., Matak, D., Szymański, Ł., Lian, F., Kornakiewicz, A., Bartnik, E., Kukwa, W., Kiéda, C., & Szczylik, C. A. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9611-y · Cited by 103 · see citing works

PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma

Mohlin, S., Hamidian, A., von Stedingk, K., Bridges, E., Wigerup, C., Bexell, D., & Påhlman, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0708 · Cited by 104 · see citing works

HIF and pulmonary vascular responses to hypoxia

Shimoda, L. A., & Laurie, S. S. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00643.2013 · Cited by 95 · see citing works

Emerging evidence of epithelial‐to‐mesenchymal transition in lung carcinogenesis

Sato, M., Shames, D. S., & Hasegawa, Y. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02173.x · Cited by 94 · see citing works

The Inflammatory Tumor Microenvironment, Epithelial Mesenchymal Transition and Lung Carcinogenesis

Heinrich, E. L., Walser, T. C., Krysan, K., Liclican, E. L., Grant, J. L., Rodriguez, N., & Dubinett, S. M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0089-0 · Cited by 84 · see citing works

Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1–dependent apoptotic pathway

Sun, H.-X., Xu, Y., Yang, X., Wang, W., Bai, H., Shi, R.-Y., Nayar, S. K., Devbhandari, R. P., He, Y.-Z., Zhu, Q.-F., et al. (2012) · Hepatology · doi:10.1002/hep.26188 · Cited by 79 · see citing works

HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer

Jackson, A. L., Zhou, B. R., & Kim, W. Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.511617 · Cited by 79 · see citing works

Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG–EGFR/ErbB4 autocrine loop

Stiehl, D. P., Bordoli, M. R., Abreu‐Rodríguez, I., Wollenick, K., Schraml, P., Gradin, K., Poellinger, L., Kristiansen, G., & Wenger, R. H. (2011) · Oncogene · doi:10.1038/onc.2011.417 · Cited by 78 · see citing works

Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells

Shin, D. H., Dier, U., Melendez, J. A., & Hempel, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.001 · Cited by 75 · see citing works

Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis

Stockmann, C., Kerdiles, Y. M., Nomaksteinsky, M., Weidemann, A., Takeda, N., Doedens, A. L., Torres‐Collado, A. X., Iruela‐Arispe, M. L., Nizet, V., & Johnson, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912766107 · Cited by 76 · see citing works

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Adelaiye-Ogala, R. M., Budka, J. A., Damayanti, N. P., Arrington, J. V., Ferris, M. W., Hsu, C.-C., Chintala, S., Orillion, A. R., Miles, K. M., Shen, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0899 · Cited by 75 · see citing works

Metabolic rewiring in mutant Kras lung cancer

Kerr, E. M., & Martins, C. P. (2017) · FEBS Journal · doi:10.1111/febs.14125 · Cited by 74 · see citing works

Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors

Nilsson, M. B., Zage, P. E., Zeng, L., Xu, L., Cascone, T., Wu, H. K., Saigal, B., Zweidler‐McKay, P. A., & Heymach, J. V. (2010) · Oncogene · doi:10.1038/onc.2010.60 · Cited by 73 · see citing works

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal

Zhou, B. R., Damrauer, J. S., Bailey, S. T., Hadzic, T., Jeong, Y., Clark, K. S., Fan, C., Murphy, L. L., Lee, C. Y., Troester, M. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69804 · Cited by 70 · see citing works

HIF-1α Metabolic Pathways in Human Cancer

Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 67 · see citing works

Map2k4 Functions as a Tumor Suppressor in Lung Adenocarcinoma and Inhibits Tumor Cell Invasion by Decreasing Peroxisome Proliferator-Activated Receptor γ2 Expression

Ahn, Y., Yang, Y., Gibbons, D. L., Creighton, C. J., Yang, F., Wistuba, I. I., Lin, W., Thilaganathan, N., Alvarez, C. A., Roybal, J. D., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05562-11 · Cited by 68 · see citing works

HIF modulation of Wnt signaling regulates skeletal myogenesis <i>in vivo</i>

Majmundar, A. J., Lee, D. S. M., Skuli, N., Mesquita, R. C., Kim, M. N., Yodh, A. G., Nguyen-McCarty, M., Li, B., & Simon, M. C. (2015) · Development · doi:10.1242/dev.123026 · Cited by 67 · see citing works

DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia

Lachance, G., Uniacke, J., Audas, T. E., Holterman, C. E., Franovic, A., Payette, J., & Lee, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322909111 · Cited by 61 · see citing works

Mimicking Tumor Hypoxia in Non-Small Cell Lung Cancer Employing Three-Dimensional In Vitro Models

Ziółkowska‐Suchanek, I. (2021) · Cells · doi:10.3390/cells10010141 · Cited by 60 · see citing works

Toward Decoding the Principles of Cancer Metastasis Circuits

Lu, M., Jolly, M. K., Onuchic, J. N., & Ben‐Jacob, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3367 · Cited by 56 · see citing works

Modulating tumor physical microenvironment for fueling CAR-T cell therapy

Luo, Z. Y., Yao, X., Li, M., Fang, D., Fei, Y., Cheng, Z., Xu, Y., & Zhu, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114301 · Cited by 58 · see citing works

The HIF-2α-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization

Pietras, A., Johnsson, A. S., & Påhlman, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_72 · Cited by 58 · see citing works

Mitochondrial biology in cancer stem cells

Loureiro, R., Mesquita, K. A., Novais, S. M., Oliveira, P. J., & Vega‐Naredo, I. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.012 · Cited by 59 · see citing works

Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression

Westerlund, I., Shi, Y., Toskas, K., Fell, S. M., Li, S., Surova, O. V., Södersten, E., Kogner, P., Nyman, U., Schlisio, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700655114 · Cited by 57 · see citing works

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma

Wang, Y., Hou, N., Cheng, X., Zhang, J., Tan, X., Zhang, C., Tang, Y., Teng, Y., & Yang, X. Y. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19108 · Cited by 57 · see citing works

Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options

Nölting, S., Grossman, A. B., & Pacák, K. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0715-1888 · Cited by 56 · see citing works

Isolation of Epithelial, Endothelial, and Immune Cells from Lungs of Transgenic Mice with Oncogene-Induced Lung Adenocarcinomas

Bantikassegn, A., Song, X., & Politi, K. A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0312ma · Cited by 56 · see citing works

Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer

Zhou, R., Zhou, X., Yin, Z., Guo, J., Hu, T., Jiang, S., Liu, L., Dong, X., Zhang, S., & Wu, G. (2015) · Oncotarget · doi:10.18632/oncotarget.6338 · Cited by 56 · see citing works

Hypoxia‐sensitive LINC 01436 is regulated by E2F6 and acts as an oncogene by targeting miR‐30a‐3p in non‐small cell lung cancer

Yuan, S., Xiang, Y., Wang, G., Zhou, M., Meng, G., Liu, Q., Hu, Z., Li, C., Xie, W., Wu, N., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12437 · Cited by 56 · see citing works

Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion

Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O’Neill, C. F., Parekh, D. J., Yeh, I., Sun, L., & Block, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 52 · see citing works

HIF Signaling Pathway in Pheochromocytoma and Other Neuroendocrine Tumors

Jochmanová, I., Zelinka, T., Widimsky, J., Jr., & Pacák, K. (2014) · Physiological Research · doi:10.33549/physiolres.932789 · Cited by 49 · see citing works

The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial–mesenchymal transition induced by hypoxia and TGF-β1

Lin, G., Gai, R., Chen, Z., Wang, Y., Liao, S., Dong, R., Zhu, H., Gu, Y., He, Q., & Yang, B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.011 · Cited by 48 · see citing works

Cell metabolism under microenvironmental low oxygen tension levels in stemness, proliferation and pluripotency.

de Miguel, M., Alcaina, Y., de la Maza, D. S., & López-Iglesias, P. (2015) · Current molecular medicine · doi:10.2174/1566524015666150505160406 · Cited by 46 · see citing works

The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer

Putra, A. C., Eguchi, H., Lee, K. L., Yamane, Y., Gustine, E., Isobe, T., Nishiyama, M., Hiyama, K., Poellinger, L., & Tanimoto, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134496 · Cited by 45 · see citing works

Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma

Wang, Z., Wei, Y., Zhang, R., Su, L., Gogarten, S. M., Liu, G., Brennan, P., Field, J. K., McKay, J., Lissowska, J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.024 · Cited by 45 · see citing works

Ubiquitination and the Ubiquitin–Proteasome System as regulators of transcription and transcription factorsin epithelial mesenchymal transition of cancer

Voutsadakis, I. A. (2012) · Tumor Biology · doi:10.1007/s13277-012-0355-x · Cited by 46 · see citing works

The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance

Prete, A. D., Sozio, F., Schioppa, T., Ponzetta, A., Vermi, W., Calza, S., Bugatti, M., Salvi, V., Bernardini, G., Benvenuti, F., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0168 · Cited by 44 · see citing works

Role of Hypoxia and HIF2α in Development of the Sympathoadrenal Cell Lineage and Chromaffin Cell Tumors with Distinct Catecholamine Phenotypic Features

Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42 · see citing works

Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis

Qiu, W., & Su, G. H. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9408-2 · Cited by 42 · see citing works

Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia

Aquino‐Gálvez, A., González-Ávila, G., DELGADO-TELLO, J., Castillejos-López, M. D. J., Mendoza-Milla, C., Zúñiga, J., Checa, M., Maldonado-Martínez, H. A., TRINIDAD-LÓPEZ, A., Cisneros, J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4399 · Cited by 40 · see citing works

Alveolar Hypoxia Promotes Murine Lung Tumor Growth through a VEGFR-2/EGFR-Dependent Mechanism

Karoor, V., Le, M., Merrick, D. T., Fagan, K. A., Dempsey, E. C., & Miller, Y. E. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0069-t · Cited by 40 · see citing works

HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma

Wang, X., Dong, J., Jia, L., Zhao, T., Lang, M., Li, Z., Lan, C., Li, X., Hao, J., Wang, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.032 · Cited by 39 · see citing works

Hypoxic‐stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non‐small cell lung cancer

Xu, X., Bao, Y., Wang, X., Yan, F., Guo, S., Ma, Y., Xu, D., Li, J., Xu, J., & Wang, J. (2018) · The FASEB Journal · doi:10.1096/fj.201700715 · Cited by 38 · see citing works

Expression and stability of hypoxia inducible factor 1α in osteosarcoma

El-Naggar, A. M., Clarkson, P. W., Zhang, F., Mathers, J. A., Tognon, C. E., & Sorensen, P. H. B. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24191 · Cited by 37 · see citing works

Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia

Xi, Y., Wei, Y., Sennino, B., Ulsamer, A., Kwan, I., Brumwell, A. L., Tan, K., Aghi, M. K., McDonald, D. M., Jablons, D. M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.530 · Cited by 36 · see citing works

Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells

Kitajima, S., Lee, K. L., Fujioka, M., Sun, W., You, J., Chia, G. S., Wanibuchi, H., Tomita, S., Araki, M., Kato, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24919 · Cited by 35 · see citing works

Differential regulation of HIF-1α and HIF-2α in neuroblastoma: Estrogen-related receptor alpha (ERRα) regulates HIF2A transcription and correlates to poor outcome

Hamidian, A., von Stedingk, K., Thorén, M. M., Mohlin, S., & Påhlman, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.083 · Cited by 35 · see citing works

Progression of Human Bronchioloalveolar Carcinoma to Invasive Adenocarcinoma Is Modeled in a Transgenic Mouse Model of K-ras–Induced Lung Cancer by Loss of the TGF-β Type II Receptor

Borczuk, A., Solé, M., Lü, P., Chen, J., Wilgus, M., Friedman, R. A., Albelda, S. Μ., & Powell, C. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1590 · Cited by 34 · see citing works

Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma

Sethi, N. S., Kikuchi, O., McFarland, J. M., Zhang, Y., Chung, M., Kafker, N., Islam, M., Lampson, B. L., Chakraborty, A. A., Kaelin, W. G., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128439 · Cited by 33 · see citing works

Clinicopathological and prognostic significance of HIF-1α and HIF-2α expression in small cell lung cancer

Luan, Y., Gao, C., Miao, Y., Li, Y., Wang, Z., & Qiu, X. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2012.10.017 · Cited by 31 · see citing works

miRNA‐214 is related to invasiveness of human non‐small cell lung cancer and directly regulates alpha protein kinase 2 expression

Salim, H., Arvanitis, A., Petris, L. D., Kanter, L., Hååg, P., Zovko, A., Özata, D. M., Lui, W., Lundholm, L., Zhivotovsky, B., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22085 · Cited by 31 · see citing works

Coexpression of hypoxia‐inducible factor‐2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma

Zhou, C., Liu, J., Tang, Y., Zhu, G., Zheng, M. H., Jiang, J. D., Yang, J., & Liang, X. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01114.x · Cited by 30 · see citing works

H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer

Bacci, L., Aiello, A., Ripoli, C., Loria, R., Pugliese, D., Pierconti, F., Rotili, D., Strigari, L., Pinto, F., Bassi, P. F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164012 · Cited by 29 · see citing works

Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy

Yastrebova, M. A., Khamidullina, A. I., Tatarskiy, V. V., & Scherbakov, A. M. (2021) · Acta Naturae · doi:10.32607/actanaturae.11062 · Cited by 28 · see citing works

MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer

Cui, J., Duan, B., Zhao, X., Chen, Y., Sun, S., Deng, W., Zhang, Y., Du, J., Chen, Y., & Gu, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5237-1 · Cited by 26 · see citing works

A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7

Cui, X., Skretting, G., Tinholt, M., Stavik, B., Dahm, A. E. A., Sahlberg, K. K., Kanse, S. M., Iversen, N., & Sandset, P. M. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.07.013 · Cited by 24 · see citing works

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

Atmaca, A., Wirtz, R., Werner, D., Steinmetz, K., Claas, S., Brueckl, W. M., Jäger, E., & Al‐Batran, S. (2015) · BMC Cancer · doi:10.1186/s12885-015-1310-1 · Cited by 23 · see citing works

Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer

Mendes, C., & Serpa, J. (2019) · Antioxidants · doi:10.3390/antiox8120603 · Cited by 21 · see citing works

Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer

Otálora-Otálora, B. A., López-Kleine, L., & Rojas, A. P. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45010029 · Cited by 20 · see citing works

DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells

Murakami, K., Wu, Y., Imaizumi, T., Yuka, A. O. K. I., Liu, Q., Xu, Y. A. N., Seino, H., Yoshizawa, T., Morohashi, S., Kato, Y., et al. (2017) · Biomedical Research · doi:10.2220/biomedres.38.221 · Cited by 22 · see citing works

Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7

Wang, J., Wang, M.-J., Lu, X., Zhang, J., Liu, Q., Zhou, D., Dai, J., & Zheng, H. (2020) · Bioengineered · doi:10.1080/21655979.2020.1834727 · Cited by 21 · see citing works

Novel insights into the molecular origins and treatment of lung cancer

Webb, J. D., & Simon, M. C. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13588 · Cited by 21 · see citing works

Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation

Mu, H., Ge, Y. P., Li, H., Wang, M., Cui, Y., Zhang, T., Song, T., & Liu, C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00625-w · Cited by 21 · see citing works

SIPA1 Enhances Aerobic Glycolysis Through HIF-2α Pathway to Promote Breast Cancer Metastasis

Yao, C., Weng, J., Feng, L., Zhang, W., Xu, Y. K., Zhang, P., Tanaka, Y., & Su, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.779169 · Cited by 20 · see citing works

Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives

Zahan, T., Das, P. K., Akter, S. F., Habib, R., Rahman, M. H., Karim, M. R., & Islam, F. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620999200730161829 · Cited by 20 · see citing works

Hypoxia‐inducible factor‐targeting prodrug TOP 3 combined with gemcitabine or TS ‐1 improves pancreatic cancer survival in an orthotopic model

Hoang, N. T. H., Kadonosono, T., Kuchimaru, T., & Kizaka‐Kondoh, S. (2016) · Cancer Science · doi:10.1111/cas.12982 · Cited by 18 · see citing works

UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation

Wang, Y., Liu, X., Wang, M., Wang, Y., Wang, S., Jin, L., Liu, M., Zhou, J. Y., & Chen, Y. (2023) · Oncogene · doi:10.1038/s41388-023-02842-z · Cited by 16 · see citing works

HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells

Shao, J.-S., Sun, J., Wang, S., Chung, K., Du, J. T., Wang, J., Qiu, X.-S., Wang, E., & Wu, G. (2017) · Tumor Biology · doi:10.1177/1010428317717137 · Cited by 16 · see citing works

OCT4B mediates hypoxia-induced cancer dissemination

Lin, S.-C., Chung, C.-H., Chung, C.-H., Kuo, M.-H., Hsieh, C.-H., Chiu, Y.-F., Shieh, Y., Chou, Y., & Wu, C.-W. (2018) · Oncogene · doi:10.1038/s41388-018-0487-6 · Cited by 15 · see citing works

HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice.

Hayes, D. N., Jackson, A. L., Kaelin, W. G., Brandstetter, K. A., Ospina, B., Zhou, B., Weigman, V., Nikolinakos, P. G., Wong, K., Naumov, G. N., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/7bk9-pm54 · Cited by 15 · see citing works

HIF-2α deletion promotes Kras-driven lung tumor development

Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130 · see citing works

Role of hypoxia‑inducible factor‑2α in lung cancer (Review)

Wang, W., Ouyang, C., Yu, B., Chen, C., Xu, X., & Ye, X. (2021) · Oncology Reports · doi:10.3892/or.2021.8008 · Cited by 20 · see citing works

HIF-2α not HIF-1α overexpression confers poor prognosis in non–small cell lung cancer

Gao, Z., Wang, Y., Yuan, W.-D., Yuan, J.-Q., & Yuan, K. (2017) · Tumor Biology · doi:10.1177/1010428317709637 · Cited by 37 · see citing works

Correlations of hypoxia-inducible factor-1α/hypoxia-inducible factor-2α expression with angiogenesis factors expression and prognosis in non-small cell lung cancer.

Wu, X.-H., Qian, C., & Yuan, K. (2011) · PubMed · Cited by 47 · see citing works